Date | Time | Source | Headline | Symbol | Company |
06/01/2024 | 9:00AM | Business Wire | Ankyra Therapeutics Announces Trial in Progress Poster Presentation at 2024 ASCO Meeting and Approval of ANK-101 Phase 1 Protocol Amendment | | |
06/01/2024 | 9:00AM | Business Wire | Sally Hansen® and GLAAD Reprise Their Partnership for the 6th Year With a Launch That Celebrates the LGBTQ+ Community | | |
06/01/2024 | 9:00AM | PR Newswire (Canada) | Statement by Minister Khera on Italian Heritage Month | | |
06/01/2024 | 9:00AM | PR Newswire (US) | Vincent Todd Announces the Introduction of Todd Agriscience | | |
06/01/2024 | 9:00AM | PR Newswire (US) | Beverly Hills MD Celebrates Its 10th Anniversary | | |
06/01/2024 | 9:00AM | PR Newswire (Canada) | Déclaration de la ministre Khera à l'occasion du Mois du patrimoine italien | | |
06/01/2024 | 9:00AM | PR Newswire (US) | American Cancer Society and American Society of Clinical Oncology Unite to Create One of the Largest and Most Comprehensive Online Sources of Credible Cancer Information | | |
06/01/2024 | 9:00AM | PR Newswire (Canada) | Déclaration du premier ministre à l'occasion du Mois national de l'histoire autochtone | | |
06/01/2024 | 9:00AM | PR Newswire (Canada) | Déclaration de la ministre Khera à l'occasion du Mois du patrimoine portugais | | |
06/01/2024 | 9:00AM | PR Newswire (Canada) | Statement by the Prime Minister on National Indigenous History Month | | |
06/01/2024 | 9:00AM | PR Newswire (Canada) | Déclaration de la ministre Khera à l'occasion du Mois du patrimoine philippin | | |
06/01/2024 | 9:00AM | PR Newswire (Canada) | Statement by Minister Khera on Filipino Heritage Month | | |
06/01/2024 | 9:00AM | PR Newswire (Canada) | Statement by Minister Khera on Portuguese Heritage Month | | |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:MKS | Marks And Spencer Group Plc |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:CRDA | Croda International Plc |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:INCH | Inchcape Plc |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:TKO | Taseko Mines Limited |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:CCH | Coca-cola Hbc Ag |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:CRDA | Croda International Plc |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:CCH | Coca-cola Hbc Ag |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:ALPH | Alpha Group International Plc |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:W7L | Warpaint London Plc |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:TXP | Touchstone Exploration Inc |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:BYG | Big Yellow Group Plc |
06/01/2024 | 8:58AM | Alliance News | DIRECTOR DEALINGS: Coca-Cola HBC, M&S and Elementis execs sell shares | LSE:ELM | Elementis Plc |
06/01/2024 | 8:30AM | PR Newswire (Canada) | Message from the Governor General on National Indigenous History Month | | |
06/01/2024 | 8:30AM | PR Newswire (US) | Xtalks Announces its Life Science Webinar Calendar for June 2024 | | |
06/01/2024 | 8:30AM | PR Newswire (Canada) | Message de la gouverneure générale à l'occasion du Mois national de l'histoire autochtone | | |
06/01/2024 | 8:15AM | GlobeNewswire Inc. | Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting | NASDAQ:YMAB | Y mAbs Therapeutics Inc |
06/01/2024 | 8:10AM | Business Wire | Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting | NYSE:NUVB | Panacea Acquisition Corp |